Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

TARS Stock Annual Income Statement. Download in Excel

Tarsus Pharmaceuticals Inc. logo

Tarsus Pharmaceuticals Inc.

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

52.91
 
USD
  
0.91
  
(1.75%)
Previous close: 52.0  Open: 50.52  Bid: 52.0  Ask: 54.25
52 week range    
18.99   
   56.77
Mkt Cap: 2,036 M  Avg Vol (90 Days): 687,424
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 23rd December 2024

Stock Rankings

53
MarketXLS Rank
40
Value
84
Technical
36
Quality
How are these ranks calculated?
Search for a stock

Financials

TARS Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23
Amortization of intangibles4 M
Basic EPS from continuing operations-4.32-0.67-2.52-4.62
Basic EPS total-4.32-0.67-2.52-4.62
Basic weighted shares outstanding6 M21 M25 M29 M
Cost of sales2 M955000.02 M
Depreciation100000.0300000.0325000.0744000.0
DepreciationAndAmortization100000.0300000.0325000.0744000.0
Diluted EPS total-4.32-0.67-2.52-4.62
Diluted normalized net income/share-0.67-2.52-4.62
Diluted weighted shares outstanding21 M25 M29 M
GainOnSaleOfSecurity-987000.0-501000.0117000.0
GeneralAndAdministrativeExpense8 M27 M45 M109 M
Gross operating profit55 M25 M16 M
Income before tax-27 M-14 M-62 M-136 M
Income taxes1000.055000.0-4000.0-4 M
Interest income188000.036000.03 M10 M
InterestExpenseNonOperating2 M3 M
InterestExpenseOperating2 M3 M
MiscOtherSpecialCharges-73000.086000.0-102000.0
Net income from total operations-27 M-14 M-62 M-136 M
NetIncomeCommonStockholders-27 M-14 M-62 M-136 M
NetIncomeContinuousOperations-27 M-14 M-62 M-136 M
NetNonOperatingInterestIncomeExpense188000.036000.01 M7 M
Normalized income-140 M
Operating income-27 M-12 M-63 M-143 M
Operating income before depreciation (EBITDA)-27 M-13 M-60 M-132 M
OperatingExpense27 M69 M88 M159 M
Other income net15000.02 M-683000.0274000.0
OtherGandA8 M27 M45 M109 M
OtherImpairmentOfCapitalAssets15000.02000.0
OtherOperatingExpenses-217000.0645000.0813000.0-468000.0
PromotionAndAdvertising9 M
RentAndLandingFees2 M
Research & development expense19 M42 M43 M50 M
ResearchExpense19 M42 M43 M50 M
Revenue per share174000.04 M
Selling Gen & administrative expense8 M27 M45 M109 M
SellingAndMarketingExpense9 M
Special income/charges-955000.0
Total Income available for interest expense (EBIT)-27 M-14 M-60 M-133 M
Total common shares outstanding21 M21 M27 M34 M
Total net income-27 M-14 M-62 M-136 M
Total ordinary shares38 M38 M38 M38 M
Total revenues57 M26 M17 M
TotalExpenses27 M71 M89 M161 M
TotalRevenue57 M26 M17 M
WriteOff955000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University